Business
Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.
Conversation Centered Around Healthcare Communications and Pandemic PreparednessLOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and infectious disease therapies, today announced that Chief Executive Officer, Brad Burnam, spoke with Dr. Robert Redfield, M.D., former Director of the Centers for Disease Control and Prevention (CDC) about healthcare communication and ways to restore
About this update from Turn Therapeutics Inc.
[{"type":"image","alt":"Turn Therapeutics","displaySize":"","headline":null,"caption":"Turn Therapeutics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":101,"url":"https://media.zenfs.com/en/globenewswire.com/2e45caf24b7062b91032e0e4351b1e39"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/uTv2v5jICXhGET5aPRSD4w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/2e45caf24b7062b91032e0e4351b1e39","width":300,"height":101}},"lazy":false},{"type":"text","content":"Conversation Centered Around Healthcare Communications and Pandemic Preparedness","length":80,"tagName":"p"},{"type":"text","content":"LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and infectious disease therapies, today announced that Chief Executive Officer, Brad Burnam, spoke with Dr. Robert Redfield, M.D., former Director of the Centers for Disease Control and Prevention (CDC) about healthcare communication and ways to restore public trust in science. The interview, titled “Redfield’s Warning: Former CDC Director on COVID’s Biggest Casualty-Trust in Science,” can be accessed on all major podcast platforms, via YouTube here, or on the Turn Therapeutics IR Website here.","length":670,"tagName":"p"},{"type":"text","content":"“It was a pleasure speaking with Dr. Redfield about re-improving public trust in health authorities,” said Bradley Burnam, Founder and Chief Executive Officer of Turn Therapeutics. “There is an obligation that companies and public health authorities have to report fact-based science to the American people. Dr. Redfield is a champion of that sentiment. I look forward to continuing the conversation not only with Dr. Redfield but with other, similar, government officials so that both biotech executives and other public facing health figures can further restore public trust in science.”","length":589,"tagName":"p"},{"type":"text","content":"Dr. Robert Redfield, M.D., is a virologist who served as the director for the CDC from 2018 to 2021. During his tenure, Dr. Redfield was a strong advocate for science-based and data-driven decision-making. Earlier in his career, Dr. Redfield made several important early contributions to the scientific understanding of HIV including the ...